Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Shupe

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Optometry and Vision Science : Official Publication of the American Academy of Optometry|September 29, 2017
Case Report: Use of Self-retained Cryopreserved Amniotic Membrane in the Treatment of Acute Chemical Ocular BurnAdam T Shupe, Anny M S Cheng
Redox Report : Communications in Free Radical Research|July 14, 2016
Pharmacologic interception of heme: a potential therapeutic strategy for the treatment of β thalassemia?M D Scott, L Yang, P Ulrich, et al.
Current Pharmaceutical Biotechnology|June 23, 2007
Microarray RNA/DNA in different stem cell linesA C Piscaglia, T Shupe, A Gasbarrini, et al.
Clinical Ophthalmology (Auckland, N.Z.)|September 18, 2023
Association of Treatment Duration and Clinical Outcomes in Dry Eye Treatment with Sutureless Cryopreserved Amniotic MembraneMarguerite McDonald, Susan B Janik, Frank W Bowden, et al.
Clinical Ophthalmology (Auckland, N.Z.)|April 20, 2018
Treatment outcomes in the DRy Eye Amniotic Membrane (DREAM) studyMarguerite B McDonald, Hosam Sheha, Sean Tighe, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Optometry and Vision Science : Official Publication of the American Academy of Optometry|September 29, 2017
Case Report: Use of Self-retained Cryopreserved Amniotic Membrane in the Treatment of Acute Chemical Ocular BurnAdam T Shupe, Anny M S Cheng
Redox Report : Communications in Free Radical Research|July 14, 2016
Pharmacologic interception of heme: a potential therapeutic strategy for the treatment of β thalassemia?M D Scott, L Yang, P Ulrich, et al.
Current Pharmaceutical Biotechnology|June 23, 2007
Microarray RNA/DNA in different stem cell linesA C Piscaglia, T Shupe, A Gasbarrini, et al.
Clinical Ophthalmology (Auckland, N.Z.)|September 18, 2023
Association of Treatment Duration and Clinical Outcomes in Dry Eye Treatment with Sutureless Cryopreserved Amniotic MembraneMarguerite McDonald, Susan B Janik, Frank W Bowden, et al.
Clinical Ophthalmology (Auckland, N.Z.)|April 20, 2018
Treatment outcomes in the DRy Eye Amniotic Membrane (DREAM) studyMarguerite B McDonald, Hosam Sheha, Sean Tighe, et al.
Pageof 1